The Joint Corp.

JYNT Healthcare Medical Care Facilities

In the quarter to June 2026, revenue grew 14.4%, EPS grew 400.0% and free cash flow grew 432.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

7.03 0.12 +1.74%
Market cap
$97.7M
P/E
26.0×
Fwd P/E
16.9×
Dividend yield
—
F-score
7/9
Altman Z
2.39
Beneish M
−2.27
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 770.37 70.17 28.24 125.70 451.48 0.00 0.00 45.89
Piotroski F-Score
4 5 7 5 5 5 6 4 7 7
P/S ratio
1.64 2.60 3.10 4.60 6.27 11.76 1.97 2.95 3.04 2.40
Altman Z-Score
(2.10) 0.39 2.41 3.80 5.79 10.97 2.85 1.70 1.98 2.39
P/FCF ratio
0.00 0.00 28.34 93.05 65.38 172.09 0.00 31.52 53.68 0.00
Altman Z″-Score (non-manufacturers)
(10.80) (7.05) (4.84) (1.87) 0.75 0.97 (0.20) 0.43 1.12 0.99
P/Operating CF
(66.81) 42.72 31.91 79.18 86.00 675.51 38.54 41.03 38.40 45.55
Beneish M-Score
(3.28) (3.16) (3.72) (0.93) (2.53) (2.12) (2.74) (4.18) (3.58) (2.27)
P/B ratio
4.86 56.27 156.30 38.99 17.41 31.04 6.12 5.60 7.67 8.75
Price to Tangible BV
18.32 0.00 0.00 0.00 26.97 45.86 15.15 11.20 9.65 12.17
EV/Sales
1.48 2.47 2.89 4.47 5.99 11.56 1.91 2.63 2.58 2.00
EV/EBITDA
0.00 0.00 62.32 40.79 42.76 92.04 25.82 13.89 47.51 137.04
EV/Operating CF
(2.81) (831.05) 19.42 28.82 31.46 66.80 23.51 8.42 14.30 59.66
EV/FCF
(2.39) (72.59) 26.38 90.43 62.54 169.20 (65.11) 28.07 45.56 (22.20)
Quick Ratio
0.75 1.01 0.94 0.83 1.24 1.10 0.62 0.65 0.58 0.83
Current Ratio
0.97 1.24 1.10 0.98 1.37 1.25 0.76 1.32 1.52 1.59
Net Debt/EBITDA
0.24 2.45 (4.56) (1.18) (1.94) (1.77) (1.14) (1.93) (9.18) (30.37)
Debt/Assets
1.94% 5.97% 4.70% 5.43% 7.38% 2.40% 2.21% 2.29% 0.00% 0.00%
Debt/Equity
0.05 0.95 1.51 0.41 0.23 0.07 0.06 0.08 0.00 0.00
Asset Turnover
0.81 1.40 1.75 1.44 1.07 1.05 1.12 0.52 0.61 0.76
Operating CF/Net income
0.71 0.02 37.17 2.26 0.85 1.83 13.10 (1.51) (1.62) 0.63
Capex/Depreciation
(0.74) (0.22) (0.71) (2.19) (1.53) (1.78) (0.89) (0.58) (0.25) (0.88)
ROE
(109.94%) (84.97%) 15.60% 103.09% 98.09% 29.42% 1.99% (34.00%) (25.51%) 16.26%
ROA
(60.19%) (19.34%) 0.70% 9.90% 24.03% 9.89% 0.69% (10.79%) (6.81%) 4.03%
ROIC
(239.74%) 0.00% 0.00% 0.00% 66.43% 30.67% 2.15% 2.63% 0.00% 0.00%
Return on Tangible Assets
(332.94%) (67.41%) 3.13% 52.60% 84.21% 38.13% 5.28% (66.95%) (20.17%) 12.96%
Average Days of Receivables
18.92 16.67 8.03 19.93 12.83 16.88 14.10 20.05 18.10 18.95
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
129.15% 90.66% 81.99% 77.31% 74.98% 77.83% 83.15% 74.34% 78.79% 78.21%
Intangible Assets out of Total Assets
0.30 0.25 0.21 0.17 0.11 0.11 0.21 0.00 0.00 0.00
Share Based Compensation of Revenue
5.47% 2.39% 1.71% 1.49% 1.51% 1.32% 1.26% 3.70% 3.22% 2.36%
Graham Net Nets
(0.13) (0.16) (0.10) (0.11) (0.05) (0.03) (0.22) (0.13) 0.08 0.05
Graham Number
0.00 0.00 0.11 1.46 5.62 4.99 1.24 0.00 0.00 2.06
Earnings Yield
(45.28%) (5.31%) 0.13% 1.43% 3.54% 0.80% 0.22% (7.00%) (5.36%) 2.18%
Free Cash Flow Yield
(37.86%) (1.31%) 3.53% 1.07% 1.53% 0.58% (1.49%) 3.17% 1.86% (3.74%)
Revenue per Share
1.62 1.88 2.68 3.51 4.19 5.59 6.99 3.20 3.50 3.63
Operating CF per Share
(0.85) (0.01) 0.40 0.54 0.80 0.97 0.57 1.00 0.63 0.12
Capex per Share
(0.15) (0.03) (0.08) (0.30) (0.30) (0.49) (0.41) (0.34) (0.08) (0.10)
Free Cash Flow per Share
(1.00) (0.04) 0.32 0.24 0.50 0.48 0.16 0.66 0.55 0.02
Cash per Share
0.26 0.33 0.65 0.63 1.49 1.39 0.73 1.31 1.74 1.61
Shareholders Equity per Share
0.55 0.09 0.05 0.41 1.51 2.12 2.25 1.69 1.39 1.00
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
0.55 0.09 0.05 0.41 1.51 2.12 2.25 1.69 1.39 1.00
Free Cash Flow
(12.74) (0.52) 4.34 3.36 6.99 6.85 2.31 9.68 8.23 0.33
Working Capital
(0.17) 1.29 1.03 (0.26) 6.89 5.45 (5.60) 10.76 25.54 19.27
Capital Expenditures
(1.89) (0.45) (1.11) (4.17) (4.20) (6.99) (5.90) (5.00) (1.19) (1.50)
Net Current Asset Value
(4.43) (10.61) (11.40) (24.68) (19.41) (29.86) (43.29) (18.10) 12.10 6.20
EV/EBIT
0.00 0.00 742.43 63.48 64.05 150.97 233.06 388.28 0.00 0.00
Capex to Sales
0.09 0.02 0.03 0.09 0.07 0.09 0.06 0.11 0.02 0.03
Price to Operating Income
0.00 0.00 797.52 65.32 66.96 153.55 240.89 436.07 0.00 0.00
Other line items
Depreciation/Fixed assets
0.54 0.53 0.43 0.29 0.31 0.27 0.38 2.26 1.47 0.54
Cash ROIC
(120.18%) (7.96%) 40.64% 20.06% 14.93% 13.10% 5.11% 21.05% 17.63% 0.85%
Accounts Receivable Turnover
21.86 22.63 37.70 28.07 24.93 27.76 26.60 14.47 20.19 20.20
Accounts Payable Turnover
1.93 3.04 3.71 4.01 4.22 4.69 3.93 4.97 7.67 6.72
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
130.98 120.98 106.13 100.06 87.59 81.22 118.07 43.66 55.49 51.66
Days of Inventory on Hand
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables
0.94 1.10 0.97 1.73 2.35 2.88 3.81 3.25 2.58 2.72
Average Payables
1.53 1.06 1.16 1.39 1.54 1.63 2.34 2.11 1.50 1.67
Average Assets
25.21 17.75 20.93 33.57 54.79 76.47 90.28 90.35 85.18 72.06
Average Common Equity
13.80 4.04 0.94 3.22 13.42 25.72 31.45 28.68 22.73 17.88

Fold the line items

Columns are period end dates